ically, the major HIV-1 strains in China appear to be circulating recombinant forms (CRF) of different clades. Hence, the HIV-1 CRF_BC strain currently accounts for over 50% of infections, while the HIV-1 Thai B (B') strain contributes to roughly 31% of total prevalence. In Taiwan, 15,011 individuals are HIV-infected, of whom 4250 have progressed to AIDS and 1870 have died cumulatively from AIDS (Figure) . The major genotype of the virus in Taiwan is subtype B and CRF_AE, with a recent emergence of CRF_BC (similar to that in China) in intravenous drug users. 7 The presence of CRF forms of HIV suggests that the viruses in China and Taiwan are evolving dynamically. The current numbers in China and Taiwan suggest a serious disease that could become much worse in the future. Going forward, now 25 years after the discovery of HIV, how should Taiwan address her AIDS/HIV question? There are no easy answers. Today, there are at least 23 US Food and Drug Administrationapproved antiretroviral drugs that can be used to treat HIV-1 in vivo. Taiwan citizens have access to several of these therapeutic drugs, which in many ways have converted HIV-1 infection from an acute death sentence to a chronic treatable disease. Nevertheless, recent failures in the development of a prophylactic HIV-1 vaccine 8 and protective microbicides 9 have cast sobering doubts on "curative" solutions. Hence, the reality is that HIV/AIDS will likely be with us for decades to come. In view of that scenario, it is mandatory that sound education, prevention, and public health measures come from both governmental and non-governmental sources. 10 One area that Taiwan should not neglect is the development of self-sufficiency in leadership for basic and clinical HIV-1 research. The virus is a clever foe with many faces; the problem that faces Asia may be sufficiently nuanced that
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